Blastic CD4 NK cell leukemia/lymphoma: a distinct clinical entity

Leuk Res. 2002 Sep;26(9):803-7. doi: 10.1016/s0145-2126(02)00014-0.

Abstract

We report the findings of three new cases of a distinct clinicopathologic natural killer (NK) cell malignancy characterized by cutaneous, nodal and bone marrow infiltration by CD3-CD4+CD56+ NK blastic cells. Tumor cells were detected in bone marrow and in peripheral blood smears and showed finely distributed nuclear chromatin with nucleoli and a moderate amount of cytoplasm. Epstein-Barr virus (EBV) DNA was negative in the two tested cases. The immunophenotypes determined by flow cytometry were identical concerning mCD3-cytCD3-CD4+weakCD56+ HLA-DR+. The TCR was in germline configuration in the two cases tested. NK cell activity was demonstrated only in one out of the two cases tested. The negative reactions with alpha-naphthyl-acetate-esterase (ANAE), CD11b and CD14 strongly suggested that the tumor cells were not of the monocytic lineage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Aged
  • Antigens, Neoplasm / analysis
  • CD56 Antigen / analysis
  • Child
  • HLA-DR Antigens / analysis
  • Herpesvirus 4, Human
  • Humans
  • Immunophenotyping
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / pathology*
  • Leukemia, Lymphoid / classification*
  • Leukemia, Lymphoid / immunology
  • Leukemia, Lymphoid / pathology
  • Leukemic Infiltration
  • Lymphatic Diseases / pathology
  • Lymphoma / classification*
  • Lymphoma / immunology
  • Lymphoma / pathology
  • Male
  • Neoplastic Stem Cells / pathology*
  • Receptors, Antigen, T-Cell, gamma-delta / genetics
  • Skin / pathology
  • Splenomegaly / pathology

Substances

  • Antigens, Neoplasm
  • CD56 Antigen
  • HLA-DR Antigens
  • Receptors, Antigen, T-Cell, gamma-delta